共 170 条
[1]
Jemal A(2011)Global cancer statistics CA Cancer J Clin 61 69-90
[2]
Bray F(2012)Review of salvage therapy for biochemically recurrent prostate cancer: the role of imaging and rationale for systemic salvage targeted anti-prostate-specific membrane antigen radioimmunotherapy Adv Urol 2012 921674-628
[3]
Center MM(2005)Fluorocholine PET/CT in patients with prostate cancer: initial experience Radiology 235 623-983
[4]
Ferlay J(2008)The value of 18F-choline PET/CT in patients with elevated PSA-level and negative prostate needle biopsy for localisation of prostate cancer Eur J Nucl Med Mol Imaging 35 976-1569
[5]
Ward E(2008)Prostate biopsy guided by 18F-fluorocholine PET in men with persistently elevated PSA levels Eur J Nucl Med Mol Imaging 35 1567-2018
[6]
Forman D(2006)Detection of pelvic lymph node metastases in patients with clinically localized prostate cancer: comparison of 18F-fluorocholine positron emission tomography-computerized tomography and laparoscopic radioisotope guided sentinel lymph node dissection J Urol 176 2014-263
[7]
Kosuri S(2008)Evaluation of [(18)F]-choline PET/CT for staging and restaging of prostate cancer Eur J Nucl Med Mol Imaging 35 253-1398
[8]
Akhtar NH(2006)18F-fluorocholine PET/CT imaging for the detection of recurrent prostate cancer at PSA relapse: experience in 100 consecutive patients Eur J Nucl Med Mol Imaging 33 1387-904
[9]
Smith M(2008)Role of whole-body 18F-choline PET/CT in disease detection in patients with biochemical relapse after radical treatment for prostate cancer Radiol Med 113 895-332
[10]
Osborne JR(2010)Pilot comparison of F-fluorocholine and F-fluorodeoxyglucose PET/CT with conventional imaging in prostate cancer J Med Imaging Radiat Oncol 54 325-48